Gene: GBA3
Official Full Name: glucosylceramidase beta 3 (gene/pseudogene)provided by HGNC
Gene Summary: The protein encoded by this gene is a cytosolic enzyme that can hydrolyze several types of glycosides. The enzyme has its highest activity at neutral pH and is predominantly expressed in human liver, kidney, intestine, and spleen. This gene is a polymorphic pseudogene, with the most common allele being the functional allele that encodes the full-length protein. Some individuals contain a single nucleotide polymorphism that results in a premature stop codon in the coding region, and therefore this allele is pseudogenic due to the failure to produce a functional full-length protein. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2022]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17425 | GBA3 Knockout cell line (HeLa) | Human | GBA3 | 1:3~1:6 | Negative | Online Inquiry |
KO17426 | GBA3 Knockout cell line (HCT 116) | Human | GBA3 | 1:2~1:4 | Negative | Online Inquiry |
KO17427 | GBA3 Knockout cell line (HEK293) | Human | GBA3 | 1:3~1:6 | Negative | Online Inquiry |
KO17428 | GBA3 Knockout cell line (A549) | Human | GBA3 | 1:3~1:4 | Negative | Online Inquiry |
GBA3 Gene Knockout Cell Lines are specialized cellular models that have been engineered to lack the GBA3 gene, known for its role in the hydrolysis of glucocerebrosides. By creating these knockout lines, researchers can observe the downstream effects of GBA3 absence, facilitating investigations into its biological functions and relevance in various pathophysiological conditions. The lack of functional gene expression allows for the elucidation of the gene’s roles in metabolism and cellular homeostasis.
The key mechanism employed in generating GBA3 knockout cell lines involves CRISPR-Cas9 technology, which enables precise genomic editing. This cutting-edge method allows for the targeted disruption of the GBA3 gene, ensuring that its functions can be studied without interference from compensatory pathways often present in wild-type cells. As a result, GBA3 knockout cell lines provide a unique platform for studying diseases associated with glucocerebroside metabolism, such as Gaucher disease and Parkinson’s disease, offering insights into therapeutic developments.
The scientific importance of GBA3 Gene Knockout Cell Lines lies in their potential applications in drug discovery and validation, as well as in the understanding of genetic conditions tied to glycosylated lipids. These cell lines serve as models for exploring the molecular mechanisms of enzyme replacement therapies and substrate reduction therapies.
Compared to alternative cellular models, such as traditional knockdown lines that may not entirely eliminate gene expression, GBA3 knockout cell lines offer a complete absence of the GBA3 protein. This defines a more accurate representation of the gene's functional roles, enhancing data reliability and reproducibility in experimental outcomes.
Researchers, clinicians, and biopharmaceutical companies will find immense value in utilizing GBA3 Gene Knockout Cell Lines to accelerate their projects in prevalent metabolic syndromes, immunology, and neurodegenerative disease research. With a commitment to quality and precision, our company is dedicated to providing top-tier biological research tools, backed by extensive industry expertise and a focus on advancing scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.